Day 1 – April 5 2016

08:00-9:15
Registration
09:15-09:30 Greetings
09:30-10:10
Plenary Session
Prof. Toshio Suda Hematopoiesis in Steady State and Under Stress
Toshio Suda M.D. PhD
Kumamoto University, Japan
japan
10:10-10:20 Poster Teasers
10:20-10:50 coffee  Coffee Break and Poster Session
10:50 -12:30 Hall A Hall B Hall C Hall D
The Biology of Pluripotency Hematopoietic and Mesenchymal Stem Cells Commercialization of Stem Cells Initiatives Stem Cell Applications in Neural Degenerative Diseases
Chair: Adi Kimchi Chair: Tsvee Lapidot Chair: Shai Yarkoni Chair: Michel Revel
10:50 -11:10 Cap-Independent Protein Translation Controls Cell Fate Decisions in Human Embryonic Stem Cells
Adi Kimchi
Weizmann Institute of Science, Israel
Israel Flag
Metabolic Regulation of Blood and Bone Forming Stem Cells: the Role of ROS and Nitric Oxide
Tsvee Lapidot
Weizmann Institute of Science, Israel
Israel Flag

Catalyzing Company Development by Exploiting Stem Cell Research Services and Technologies Developed Through Public Private Partnerships – A Danish Perspective
Bjørn Holst
Bioneer, Denmark 
denmark

Customised Single-Use-Bioreactor for Stem Cell Cultivation
Per Stobbe

PerfuseCell, Denmark
denmark

Commercialization of Stem Cell Therapy
Brian Mehling
Blue Horizon International, USA

"Cellect Inside" – the Way to Develop Disruptive Technology
Tal Almog
Cellectbio, Israel

Israel Flag

The commercialization session will bring together KOLs from Denmark, Belgium, US and Israel to discuss different types of ventures and their adaptability to stem cells technologies: Disruptive technologies, innovative products, services and combinations. Company presentations will be followed by panel discussion on the special features typical to cell (and stem cells in particular) based commercialization

 

panel

Basic Aspects of Translational Issues in Cell Therapy to the CNS
Tamir Ben Hur
Hadassah Hebrew University Medical Center, Israel
Israel Flag
11:10 -11:30 Using Patients' Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Investigating Inherited Cardiac Pathologies
Ofer Binah

Technion, Israel
Israel Flag
Vascular Stem Cell Niches
Eli Keshet
Hadassah Hebrew University Medical Center, Israel
Israel Flag
Intrathecal Transplantation of Human Astrocytes Attenuates Clinical Symptoms in SOD1G93A ALS Rat Model
Michal Izrael
Kadimastem Ltd., Israel
Israel Flag
11:30 -11:50 Molecular Mechanisms for Inducing and Resolving Pluripotency
Jacob Hanna
Weizmann Institute of Science, Israel
Israel Flag
Mesenchymal Stem Cells Sensing Mechanical Cues at Microenvironment
Dafna Benayahu
Tel Aviv University, Israel
Israel Flag
Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosi
Yael Gothelf
BrainSTorm-Cell Therapeutics Ltd., Israel
Israel Flag
11:50 -12:10 Pluripotent Genes and Pediatric Cancer Formation
Achia Urbach
Bar-Ilan University, Israel
Israel Flag
Transcription-Factors are Driving to Normal and Malignat Stem Cells
Roi Gazit
Ben-Gurion University of the Negev, Israel
Israel Flag
Enhancement of Hippocampal Neurogenesis in the Adult and Aged Brain via Conditional Manipulations of the Vascular Stem Cell Niche
Tamar Licht
The Hebrew University of Jerusalem, Israel
Israel Flag
12:10 -12:30 Complete Nuclear Reprogramming Independently of Pluripotency
Yossi Buganim
The Hebrew University of Jerusalem, Israel
Israel Flag
Live Imaging of Multipotent Angioblasts Reveals New Mechanisms of Vascular Formation
Karina Yaniv
Weizmann Institute of Science, Israel
Israel Flag
Comments on Stem cells in ALS therapy
Michel Revel
Kadimastem Ltd., Israel
Israel Flag
12:30 -12:45 Annual Meeting of the ISCS
12:30 -13:30 lunch  Lunch break
  Hall A Hall B Hall C Hall D
  Tissue Regeneration and Stem Cells Stem Cells in Neurobiology Cancer Immunotherapy Drug Discovery and Disease Modeling
13:30 -15:10
Chair: Raphael Gorodetsky Chair: Benjamin E. Reubinoff Chair: Michal Besser Chair: Arik Hasson
13:30 -13:50 Treatment with Isolated Subpopulation of Potent Human Derived Expanded Placental Stromal Cells (hPSC) for Mitigation of Radiation Effects and for Regenerative Medicine
Raphael Gorodetsky
Hadassah Hebrew University Medical Center, Israel
Israel Flag
Human Pluripotent Stem Cells Towards Clinical Applications
Benjamin Reubinoff
Hadassah Hebrew University Medical Center, Israel
Israel Flag
Adoptive Cell Therapy for Cancer
Michal Besser
Sheba Medical Center, Israel
Israel Flag

Novel Approach for Personalized Medicine of Rare Diseases
Miguel Weil
Tel Aviv University, Israel
Israel Flag
13:50 -14:10 The Dark Side of the Force: Mesenchymal Stromal Cells in Cardiac Inflammation and Fibrosis
Yoni Leor
Sheba Medical Center, Israel
Israel Flag
Molecular and Functional Deficiencies in Fragile X Neurons Derived from Human Embryonic Stem Cells
Dalit Ben-Yosef
Tel Aviv Sourasky Medical Center, Israel
Israel Flag
Personalized T Cell-Based Immunotherapy Targeting Neoantigens for Advanced Cancer Treatment
Cyrille Cohen
Bar-Ilan University, Israel
Israel Flag
The Use of Patient-Specific Induced Pluripotent Stem Cell Derived Cardiac Myocytes for Disease Modeling and Drug Screening
Naim Shaheen
Technion, Israel
Israel Flag
14:10 -14:30 Mesenchymal Stromal Cells and Their Secreted Exosomes Exert Therapeutic Impact in Brain Tumors and Degenerative Diseases va the Delivery of Non-Coding RNAS
Chaya Brodie
Bar-Ilan University, Israel
Israel Flag
Streamlined Derivation of Cortical Fates From Human Pluripotent Stem Cells Allows Standardized Modeling of Development and Disease
Yechiel Elkabetz
Tel Aviv University, Israel
Israel Flag
New Genes for Improving Safety and Clinical Efficacy of Adoptive T Cell Transfer in Cancer Immunotherapy
Gidi Gross

Migal, Israel
Israel Flag
Modeling Neuroendcrinological Disorders Using a Novel iPSC-Based Blood Brain Barrier-on-Chip
Gad Vatine
Cedars-Sinai Medical Center, USA

14:30 -14:50 A Novel Approach for Llung Regeneration by Lung Progenitors Following Clearance of the Lung Niche
Chava Rosen
Weizmann Institute of Science, Israel
Israel Flag
Life-Long Hippocampal Neurogenesis is Controlled by the Immune System through Unique Brain's Borders: Implications to Age-Related Dementia
Michal Schwartz
Weizmann Institute of Science, Israel
Israel Flag
Fighting Cancer by Mimicking the Immune System
Mira Peled-Kamar

Applied Immune Technology (AIT), Israel
Israel Flag
Colony Forming Unites - Endothelial Progenitor Cells (CFU-EPCs) – A Surrogate Marker for Diabetic Retinopathy and High Cardiovascular Mortality
Arnon Blum
Bar-Ilan University, Israel
Israel Flag
14:50 -15:10 Oral Mucosa Derived Stem Cell Cells: From Basic Science to Translational Studies
Sandu Pitaru
Tel Aviv University, Israel
Israel Flag
Long Lasting Effect of Mesenchymal Stem Cells in BTBR Autism Model in Mice
Danni Offen
Tel Aviv University, Israel
Israel Flag
A Novel Method for Enhancing Ex Vivo Expansion of Immunotherapeutic Gamma Delta T Cells
Ilan Bank
Sheba Medical Center and Gammacell Biotechnologies, Israel
Israel Flag
Identification of Function-Specific Pancreatic Progenitors by Cell-Based Proteomics
Yoav Soen
Weizmann Institute of Science, Israel
Israel Flag
15:10 -15:40 coffee  Coffee Break
15:40 -16:20
Plenary Session
Patrick McNutt Photo Functional Neurogenesis in a Dish: Deriving Human and Mouse Networked Neuron Cultures for Therapeutic Screening and Regenerative Therapies
Patrick McNutt PhD
United States Army Medical Research Institute of Chemical Defense, USA

16:20 -16:30 Poster Teasers
16:30 -17:30 Happy Hour
Day1 Day2 Poster Session